CELL SOURCE

Cell Source is a biotechnology company focused on developing cell therapy treatments based on the management of immune tolerance. Our patented Veto Cell technology is the centerpiece of treatment protocols that represent major breakthroughs in immune system management - safe and selective "tolerizing" of immune response... Cell Source is collaborating with top-tier scientists and institutions such as Dr. Zelig Eshhar, the inventor of CAR-T therapy, and the MD Anderson Cancer Center, the world leader in bone marrow transplants and cancer treatment... Cell Source is actively evaluating its Veto Cell-based therapies in Clinical and Pre-Clinical trials.

Also known as: Cell Source Inc.

Primary location: New York United States